Applied Viromics Competitors and Similar CompaniesClear all

Applied Viromics's competitors and similar companies include Resverlogix, Ionis Pharmaceuticals, Nemesis Bioscience and Chimeron Bio.
Applied Viromics
Applied Viromics
Applied Viromics is a biotech company that offers viral vectors for gene delivery.
Resverlogix
Resverlogix
Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Nemesis Bioscience
Nemesis Bioscience
Nemesis Bioscience is a biopharmaceutical company developing DNA therapeutics administered before antibiotics to inactivate resistance in bacterial pathogens.
Chimeron Bio
Chimeron Bio
Chimeron Bio is a company focused on RNA (ribonucleic acid) therapeutics.
Founding Date
Founding Date
2004
Founding Date
2001
Founding Date
1989
Founding Date
2014
Founding Date
2015
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Fremont, US HQ
Locations
Calgary, CA HQ
San Francisco, US
Locations
Carlsbad, US HQ
Vancouver, CA
Stuttgart, DE
Dublin, IE
Dublin, IE
Lisboa, PT
London, GB
see more
Locations
Babraham, GB HQ
Locations
Philadelphia, US HQ
Employees
Employees
N/A
Employees
19
Employees
1,40231% increase
Employees
N/A
Employees
12
Valuation ($)
Valuation ($)
N/A
Valuation ($)
12.9 m
Valuation ($)
6.3 b
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$943.7m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$15.9m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$50k (FY, 2025)
Gross profit
$927.8m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
($7.8m) (FY, 2025)
Net income
($381.4m) (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 908.1k (about 9 years ago)
Latest funding round
$ 845k (almost 10 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 10m
Total funding raised
N/A
Total funding raised
$ 1.4m
Total funding raised
$ 845k
For sources of this data, please see the company profile

View Company Profiles

Resverlogix
HQ
Calgary, CA
Employees
19

Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.

View company
Ionis Pharmaceuticals
HQ
Carlsbad, US
Employees
1,402↑ 31% increase

Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.

View company
Nemesis Bioscience
HQ
Babraham, GB

Nemesis Bioscience is a biopharmaceutical company developing DNA therapeutics administered before antibiotics to inactivate resistance in bacterial pathogens.

View company
Chimeron Bio
HQ
Philadelphia, US
Employees
12

Chimeron Bio is a company focused on RNA (ribonucleic acid) therapeutics.

View company